Mercy Health launches clinical trial to reduce chemotherapy nerve damage

5 articles · Updated · peakofohio.com · Apr 30

Springfield and Urbana cancer centres are enrolling patients in the IMPACT study, using Luminate's Lilac Glove & Boot during chemotherapy.
Participants will receive either the active compression device or a comparison device, while care teams monitor numbness, tingling, pain and weakness in hands and feet.
Mercy says few effective options exist to prevent chemotherapy-induced peripheral neuropathy, which can disrupt walking, work and grip and sometimes persist after treatment.

Could restricting chemotherapy to the hands and feet with pressure devices pose any unforeseen health risks for patients?

Is this device the start of a new trend in managing chemotherapy's side effects without adding more drugs?